Nanobiotix | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
8,144.90
9,556.50
17,003.10
21,880.50
26,143.20
30,345
Depreciation, Depletion & Amortization
233.90
307.60
456.10
482.80
403.90
619
Other Funds
573.20
300.20
1,278.00
1,843.70
2,927.00
2,660
Funds from Operations
7,337.80
8,948.80
15,269.00
19,554.00
22,812.40
27,066
Changes in Working Capital
500.40
376.20
1,573.50
1,198.30
1,671.20
1,078
Net Operating Cash Flow
6,837.40
8,572.60
16,842.60
18,355.70
21,141.20
25,988
Capital Expenditures
196.30
963.30
1,494.80
400.10
1,464.30
Sale of Fixed Assets & Businesses
3.60
0.00
73.00
-
-
Purchase/Sale of Investments
0.50
179.20
783.80
44.90
-
Net Investing Cash Flow
192.30
1,142.40
2,205.70
445.00
1,464.30
Issuance/Reduction of Debt, Net
365.00
1,190.00
2,291.60
1,223.80
983.40
Net Financing Cash Flow
351.20
37,721.60
3,078.10
22,967.50
48,643.00
Net Change in Cash
7,381.00
28,006.00
15,983.30
4,054.80
26,154.50
Free Cash Flow
7,033.80
9,535.90
18,329.90
18,746.60
22,605.50
Change in Capital Stock
13.80
36,531.60
786.50
21,743.80
49,626.50
Exchange Rate Effect
-
0.50
13.10
112.00
117.00
About Nanobiotix
View Profile
